IMMG — Immage Biotherapeutics Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro Cap

Annual income statement for Immage Biotherapeutics, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	2012 September 30th	2013 September 30th	2014 September 30th	2015 August 31st	2016 August 31st
Period Length:	12 M	12 M	12 M	11 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	0	0	0
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	0.002	0.012	0.019	0.054	0.216
Operating Profit	-0.002	-0.012	-0.019	-0.054	-0.216
Net Income Before Taxes	-0.002	-0.012	-0.019	-0.054	-0.216
Provision for Income Taxes
Net Income After Taxes	-0.002	-0.012	-0.019	-0.054	-0.216
Net Income Before Extraordinary Items
Net Income	-0.002	-0.012	-0.019	-0.054	-0.216
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.002	-0.012	-0.019	-0.054	-0.216
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0	-0	-0	-0.001	-0.001
Dividends per Share